Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment
Infertility affects one in six of the population and increasingly couples require treatment with
assisted reproductive techniques. In vitro fertilization (IVF) treatment is most commonly …
assisted reproductive techniques. In vitro fertilization (IVF) treatment is most commonly …
Human chorionic gonadotropin test: old uncertainties, new perspectives, and value in 46, XY disorders of sex development
S Bertelloni, G Russo, GI Baroncelli - Sexual Development, 2018 - karger.com
The human chorionic gonadotropin (hCG) test represents a key step in assessing Leydig
cell function in prepubertal males, but differences in terms of hCG doses, number of …
cell function in prepubertal males, but differences in terms of hCG doses, number of …
[HTML][HTML] The role of testosterone in spermatogenesis: lessons from proteome profiling of human spermatozoa in testosterone deficiency
G Grande, F Barrachina, A Soler-Ventura… - Frontiers in …, 2022 - frontiersin.org
Testosterone is essential to maintain qualitative spermatogenesis. Nonetheless, no studies
have been yet performed in humans to analyze the testosterone-mediated expression of …
have been yet performed in humans to analyze the testosterone-mediated expression of …
[HTML][HTML] Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and kisspeptin during IVF treatment
Objective The maturation of oocytes to acquire competence for fertilization is critical to the
success of in vitro fertilization (IVF) treatment. It requires LH-like exposure, provided by …
success of in vitro fertilization (IVF) treatment. It requires LH-like exposure, provided by …
Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function.
J Albrethsen, TH Johannsen… - The Journal of …, 2020 - academic.oup.com
Background The peptide hormone insulin-like factor 3 (INSL3) is a marker for Leydig cell
function and the clinical use of serum INSL3 measurements has been suggested by several …
function and the clinical use of serum INSL3 measurements has been suggested by several …
Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism
Y Wang, C Gong, M Qin, Y Liu, Y Tian - Clinical endocrinology, 2017 - Wiley Online Library
Context The diagnosis of congenital hypogonadotropic hypogonadism (CHH) in prepuberty
has always been challenging. Here, we aimed at studying the clinical and genetic features …
has always been challenging. Here, we aimed at studying the clinical and genetic features …
Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum
J Albrethsen, H Frederiksen, AM Andersson… - Clinical Chemistry and …, 2018 - degruyter.com
Background: The circulating level of the peptide hormone insulin-like factor 3 (INSL3) is a
promising diagnostic marker reflecting Leydig cell function in the male. Few commercial …
promising diagnostic marker reflecting Leydig cell function in the male. Few commercial …
GnRH stimulation testing and serum inhibin B in males: insufficient specificity for discriminating between congenital hypogonadotropic hypogonadism from …
H Mosbah, C Bouvattier, L Maione… - Human …, 2020 - academic.oup.com
Abstract STUDY QUESTION Are GnRH tests and serum inhibin B levels sufficiently
discriminating to distinguish transient constitutional delay of growth and puberty (CDGP) …
discriminating to distinguish transient constitutional delay of growth and puberty (CDGP) …
[HTML][HTML] The influence of body composition on the response to dynamic stimulation of the endocrine pituitary-testis axis
J Abildgaard, AK Bang, L Nordkap, L Priskorn… - International Journal of …, 2024 - nature.com
Background Testosterone treatment is generally not recommended in men with obesity
induced low serum testosterone. However, distinguishing this condition from overt …
induced low serum testosterone. However, distinguishing this condition from overt …
Endocrine responses to triptorelin in healthy women, women with polycystic ovary syndrome, and women with hypothalamic amenorrhea
Context Limited data exist regarding whether the endocrine response to the gonadotropin-
releasing hormone receptor agonist (GnRHa) triptorelin differs in women with polycystic …
releasing hormone receptor agonist (GnRHa) triptorelin differs in women with polycystic …